Emory University Infla Rx N.V. Transaction History

Emory University

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 13, 2020	SELL	$2.2 - $4.54 $80,999 - $167,153	-36,818 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$2.47 - $3.51 $53,428 - $75,924	-21,631 Reduced 37.01%	36,818 $91,000
Q2 2019 Aug 14, 2019	SELL	$3.06 - $51.61 $41,111 - $693,380	-13,435 Reduced 18.69%	58,449 $185,000
Q1 2019 May 09, 2019	SELL	$31.16 - $48.62 $297,640 - $464,418	-9,552 Reduced 11.73%	71,884 $2.72 Million
Q4 2018 Feb 12, 2019	BUY	$23.33 - $36.37 $1.9 Million - $2.96 Million	81,436 New	81,436 $2.96 Million

12.9M

19.3K

Ticker IFRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,203,800
Market Cap $99M
Description
InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a nov...

Get notified when there are updates to the investment portfolio of Emory University, based on Form 13F filings with the SEC.

Stay updated on Emory University with notifications on news.